摘要:
The present disclosure relates to pesticide compositions consisting of meso-sized particles in combination with certain adjuvants such as built-in adjuvants which are added directly to the formulation or to an aqueous dilution of the formulation such as tank-mix adjuvants, to provide enhanced effectiveness for the control of agricultural pests. Mesoparticle compositions containing such adjuvants have been found to provide improved effectiveness compared to mesoparticle compositions not containing such adjuvants or to conventional formulations.
摘要:
Methods and systems are provided for automatic visual preview of non-visual data. A visual preview of non-visual data is generated by obtaining the non-visual data; obtaining metadata describing one or more semantic data types in the obtained non-visual data; selecting one or more visual metaphors for the obtained non-visual data based on the metadata; and generating the visual preview of the non-visual data using the one or more selected visual metaphors. As used herein, non-visual data does not have an established automatic method for generating a preview of the non-visual data. A user can optionally interact with the visual preview.
摘要:
The invention relates to particular substituted heterocycle fused gamma-carbolines of formula I: as described herein, their prodrugs, in free, solid, pharmaceutically acceptable salt and/or substantially pure form as described herein, pharmaceutical compositions thereof, and methods of use in the treatment of diseases involving 5-HT2A receptor, serotonin transporter (SERT) and/or pathways involving dopamine D2 receptor signaling systems.
摘要:
Disclosed are compounds and compositions of the formula I as described herein which are inhibitors of MMP-13. Also disclosed are methods of using and making compounds of the formula I.
摘要:
The present invention provides methods for the preparation of substituted 2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole derivative useful as intermediates and methods for producing and using such intermediates.
摘要:
This disclosure concerns novel quinazoline compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful anticancer agents, especially in inhibiting the function of the EGF receptor tyrosine kinases, HER1 tyrosine kinase, and HER2 tyrosine kinase. Thus, the disclosure also concerns a method of treating hyperproliferative diseases or conditions, such as various cancers and benign prostate hyperplasia (BPH), by use of these novel compounds or a composition comprising such novel compounds.
摘要:
A transmission method for synchronously transmitting asynchronous data is disclosed by the present invention, and the method includes: a transmitting end encapsulating the asynchronous data into a synchronous data frame, and synchronously transmitting it to a receiving end; and the receiving end receiving and de-encapsulating the synchronous data, writing the obtained asynchronous data into a buffer of the receiving end, reading the asynchronous data by using a reading clock of the asynchronous data and outputting the asynchronous data to a receiving apparatus for asynchronous data; wherein, the receiving end also adjusts the frequency of reading clock by using data depth information of the buffer, increases the frequency of reading clock when the data depth in the buffer increases, and outputs data representing idle when the buffer is empty. A transmission system and receiving apparatus for synchronously transmitting asynchronous data are also disclosed by the present invention.
摘要:
The invention relates to particular substituted heterocycle fused gamma-carbolines, their prodrugs, in free, solid, pharmaceutically acceptable salt and/or substantially pure form as described herein, pharmaceutical compositions thereof, and methods of use in the treatment of diseases involving 5-HT2A receptor, serotonin transporter (SERT) and/or pathways involving dopamine D2 receptor signaling systems.
摘要:
The present invention relates to compounds of formula (I): wherein R1 to R3, A, X and n are as defined herein. The compounds of formula (I) are useful as inhibitors of leukotriene A4 hydrolase (LTA4H) and treating LTA4H related disorder. The present invention also relates to pharmaceutical compositions comprising the compounds of formula (I), methods of using these compounds in the treatment of various diseases and disorders, and processes for preparing these compounds.